These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4066889)

  • 1. Planning the duration of accrual and follow-up for clinical trials.
    Morgan TM
    J Chronic Dis; 1985; 38(12):1009-18. PubMed ID: 4066889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of accrual and follow-up for two-stage clinical trials.
    Case LD; Morgan TM
    Lifetime Data Anal; 2001 Mar; 7(1):21-37. PubMed ID: 11280845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonparametric estimation of duration of accrual and total study length for clinical trials.
    Morgan TM
    Biometrics; 1987 Dec; 43(4):903-12. PubMed ID: 3427175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for predicting accrual, cost, and paper flow in clinical trials.
    Piantadosi S; Patterson B
    Control Clin Trials; 1987 Sep; 8(3):202-15. PubMed ID: 3665522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review.
    Zhang X; Long Q
    Clin Trials; 2012 Dec; 9(6):681-8. PubMed ID: 22674642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accrual by groups in trials with discrete-time survival endpoints.
    Jóźwiak K; Moerbeek M
    Clin Trials; 2013 Feb; 10(1):32-42. PubMed ID: 23203992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing clinical trials with arbitrary specification of survival functions and for the log rank or generalized Wilcoxon test.
    Halpern J; Brown BW
    Control Clin Trials; 1987 Sep; 8(3):177-89. PubMed ID: 3665521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint monitoring and prediction of accrual and event times in clinical trials.
    Zhang X; Long Q
    Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim recruitment goals in clinical trials.
    Lee YJ
    J Chronic Dis; 1983; 36(5):379-89. PubMed ID: 6853664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of additional follow-up and accrual on survival time data.
    Brookmeyer R; Self SG
    Biometrics; 1985 Mar; 41(1):129-36. PubMed ID: 3890978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planning the size of survival time clinical trials with allowance for stratification.
    Moussa MA
    Stat Med; 1988 May; 7(5):559-69. PubMed ID: 3387715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size requirements and the cost of a randomized clinical trial with repeated measurements.
    Bloch DA
    Stat Med; 1986; 5(6):663-7. PubMed ID: 3823673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring rules for stopping accrual in comparative survival studies.
    Rubinstein LV; Gail MH
    Control Clin Trials; 1982 Dec; 3(4):325-43. PubMed ID: 7160190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
    Tang C; Sherman SI; Price M; Weng J; Davis SE; Hong DS; Yao JC; Buzdar A; Wilding G; Lee JJ
    Clin Cancer Res; 2017 Mar; 23(6):1414-1421. PubMed ID: 28275168
    [No Abstract]   [Full Text] [Related]  

  • 15. Recruitment experience in clinical trials: literature summary and annotated bibliography.
    Hunninghake DB; Darby CA; Probstfield JL
    Control Clin Trials; 1987 Dec; 8(4 Suppl):6S-30S. PubMed ID: 3326716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
    Paul K; Sathianathen N; Dahm P; Le C; Konety BR
    J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
    Klabunde C; Kaluzny A; Ford L
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-function approach to the design of reliability studies.
    Eliasziw M; Donner A
    Stat Med; 1987 Sep; 6(6):647-55. PubMed ID: 3685720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time and expected value of sample information wait for no patient.
    Eckermann S; Willan AR
    Value Health; 2008; 11(3):522-6. PubMed ID: 18179665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical considerations for estimating clinical trial accrual periods: application to a multi-center effectiveness study.
    Carter RE; Sonne SC; Brady KT
    BMC Med Res Methodol; 2005 Mar; 5():11. PubMed ID: 15796782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.